Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

118.70
BATS BZX Real-Time Price
As of 3:04pm ET
 +4.10 / +3.58%
Today’s Change
110.90
Today|||52-Week Range
169.89
-17.24%
Year-to-Date

Today’s Trading

Previous close114.60
Today’s open115.83
Day’s range115.73 - 120.12
Volume15,319
Average volume (3 months)574,756
Market cap$5.0B
Dividend yield--
Data as of 3:04pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-31.68%
Earnings growth (next 5 years)-10.40%
Revenue growth (last year)+9.08%
P/E ratio13.7
Price/Sales4.20
Price/Book2.66

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-1.08-2.87%
GRFSGrifols SA+0.01+0.05%
CTLTCatalent Inc0.000.00%
PTHNPatheon NV0.000.00%
Data as of 3:08pm ET, 09/25/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$3.82
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts